We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Voyager Therapeutics
VYGR
$187M
| $488K | ﹤0.01% |
38,700
-6,700
| -15% | -$77.9K |
|
1327
iRadimed
IRMD
$1.22B
| $487K | ﹤0.01% |
21,000
+900
| +4% | +$19.3K |
|
|
MNK
1328
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $487K | ﹤0.01% |
181,800
-51,500
| -22% | -$155K |
|
|
EVRI
1329
DELISTED
Everi Holdings
EVRI
| $486K | ﹤0.01% |
94,300
-64,500
| -41% | -$328K |
|
1330
Minerva Neurosciences
NERV
$195M
| $486K | ﹤0.01% |
+16,838
| New | +$988K |
|
|
RYZ
1331
Ryerson Holding Corp
RYZ
$1.58B
| $484K | ﹤0.01% |
86,000
+13,100
| +18% | +$64.8K |
|
1332
Harvard Bioscience
HBIO
$27.6M
| $480K | ﹤0.01% |
+15,510
| New | +$418K |
|
1333
Univest Financial
UVSP
$1.23B
| $480K | ﹤0.01% |
29,800
+2,600
| +10% | +$41.7K |
|
|
SCWX
1334
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $480K | ﹤0.01% |
42,000
+2,800
| +7% | +$33.3K |
|
|
IHC
1335
DELISTED
Independence Holding Company
IHC
| $480K | ﹤0.01% |
15,700
+1,300
| +9% | +$36.3K |
|
|
HONE
1336
DELISTED
HarborOne Bancorp
HONE
| $479K | ﹤0.01% |
56,200
+4,600
| +9% | +$36.8K |
|
1337
Columbus McKinnon
CMCO
$465M
| $478K | ﹤0.01% |
14,300
+1,200
| +9% | +$33.1K |
|
|
UNIT
1338
Uniti Group
UNIT
$2.57B
| $478K | ﹤0.01% |
51,200
+1,800
| +4% | +$13.5K |
|
|
AT
1339
DELISTED
Atlantic Power Corporation
AT
| $477K | ﹤0.01% |
238,500
+19,700
| +9% | +$39.2K |
|
|
BSTC
1340
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $477K | ﹤0.01% |
7,800
+600
| +8% | +$34.7K |
|
1341
Midland States Bancorp
MSBI
$678M
| $476K | ﹤0.01% |
31,900
+7,700
| +32% | +$118K |
|
1342
NVE Corp
NVEC
$564M
| $476K | ﹤0.01% |
7,700
+600
| +8% | +$34.3K |
|
|
VIA
1343
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $476K | ﹤0.01% |
13,480
+500
| +4% | +$17.9K |
|
1344
Central Garden & Pet Co
CENT
$2.72B
| $475K | ﹤0.01% |
+16,500
| New | +$444K |
|
1345
Unisys
UIS
$244M
| $474K | ﹤0.01% |
43,500
+3,600
| +9% | +$41.6K |
|
1346
XBiotech
XBIT
$68.9M
| $472K | ﹤0.01% |
34,500
+13,007
| +61% | +$183K |
|
|
LAND
1347
Gladstone Land Corp
LAND
$366M
| $471K | ﹤0.01% |
29,753
+742
| +3% | +$10.4K |
|
1348
Scholar Rock
SRRK
$5.96B
| $471K | ﹤0.01% |
25,900
+2,100
| +9% | +$35.8K |
|
|
HSII
1349
DELISTED
Heidrick & Struggles
HSII
| $469K | ﹤0.01% |
21,700
+1,800
| +9% | +$39.6K |
|
1350
Utah Medical Products
UTMD
$217M
| $469K | ﹤0.01% |
5,300
| – | – |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.